Robert Leverette
Papers
2
Total Citations
23
H-Index
2
About
Robert Leverette is a leading researcher in the field of in vitro toxicology, with a primary focus on the development and refinement of whole smoke exposure systems for evaluating the biological impact of combustible tobacco products. His major contributions center on advancing the VITROCELL® VC10® smoke exposure platform, which enables air-liquid and air-agar interface exposures that closely mimic in vivo conditions. Leverette pioneered quantitative methods for assessing dose in these systems, moving the field beyond traditional partitioned exposures of total particulate matter and gas vapor phase. His most-cited work, “Investigation of multiple whole smoke dosimetry techniques using a VITROCELL®VC10® smoke exposure system” (2019, 13 citations), systematically compared dosimetry approaches to improve reproducibility and accuracy in toxicological testing. His 2018 paper (10 citations) established foundational protocols for dose quantification in in vitro evaluations. These contributions are instrumental in standardizing whole smoke exposure methodologies, enabling more physiologically relevant assessments of cytotoxicity and genotoxicity. Leverette’s work is widely recognized for bridging the gap between laboratory assays and real-world inhalation scenarios, making him a key figure in tobacco product evaluation and regulatory toxicology.
Research Focus
Key Achievements
Top Papers
- 1
- 2